Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64 |
filingDate |
2007-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2014-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101464651-B1 |
titleOfInvention |
Polycyclic cinnamide derivative |
abstract |
The present invention relates to a compound represented by formula (I) or a pharmacologically acceptable salt thereof. The compound or salt is useful as a therapeutic or prophylactic agent for diseases caused by A?.n n n n n n n n [Wherein,n n n Ar 1 is an imidazolyl group which may be substituted with a C 1-6 alkyl group, Ar 2 is a phenyl group which may be substituted with a C 1-6 alkoxy group, X 1 is a double bond, Het may be substituted with a C 1-6 alkyl group Gt; imidazolyl < / RTI > |
priorityDate |
2006-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |